Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ENDOCYTE INC
| Metric | ENDOCYTE INC Healthcare |
|---|---|
| Quality Score | 27 / 100 |
| Revenue (latest) | $12,000 |
| Net income (latest) | −$11M |
| Operating margin | −97725.0% |
| Net margin | −95741.7% |
| Return on equity | −12.0% |
| Return on assets | −11.4% |
| Return on capital (ROCE) | −12.2% |
| Debt / equity | 0.06× |
| Revenue growth (YoY) | 0.0% |
| Altman Z″ (distress) | 14.34 |
| Accruals / assets | 22.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.